Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly diagnosed chemotherapy Naïve Patients with Multiple Myeloma at Risk for Cancer-associated Thrombosis. The Observational ROADMAP-CAT-MM Study. Issue 164 (April 2018) - Fotiou, D.; Papageorgiou, L.; Salta, S.; Terpos, E.; Fareed, J.; VanDreden, P.; Lefkou, E.; Larsen, A.K.; Elalamy, I.; Dimopoulos, M.A.; Gerotziafas, G.T.